Literature DB >> 15353496

Value of delayed-enhancement cardiovascular magnetic resonance imaging in predicting myocardial viability after surgical revascularization.

Joseph B Selvanayagam1, Attila Kardos, Jane M Francis, Frank Wiesmann, Steffen E Petersen, David P Taggart, Stefan Neubauer.   

Abstract

BACKGROUND: Despite the accepted utility of delayed-enhancement MRI in identifying irreversible myocardial injury, no study has yet assessed its role as a viability tool exclusively in the setting of coronary artery bypass surgery (CABG), and no study has repeated delayed-enhancement MRI late after revascularization. In a clinical trial in which patients underwent CABG by either the off-pump or on-pump surgical technique, we hypothesized that (1) preoperative delayed-enhancement MRI would have high diagnostic accuracy in predicting viability and (2) the occurrence of perioperative myocardial necrosis would affect late regional wall motion recovery. METHODS AND
RESULTS: Fifty-two patients undergoing multivessel CABG were studied by preoperative and early (day 6) and late (6 months) postoperative cine MRI for global and regional functional assessment and delayed-enhancement MRI for assessment of irreversible myocardial injury. Preoperatively, 611 segments (21%) had abnormal regional function, whereas 421 segments (14%) showed evidence of hyperenhancement. At 6 months after revascularization, 57% (343 of 611) of dysfunctional segments improved contraction by at least 1 grade. When all preoperative dysfunctional segments were analyzed, there was a strong correlation between the transmural extent of hyperenhancement and the recovery in regional function at 6 months (P<0.001). Of a total of 96 previously dysfunctional but nonenhancing or minimally hyperenhancing myocardial segments that did not improve regional function at 6 months, 35 (36%) demonstrated new perioperative hyperenhancement in the early postoperative MRI scan.
CONCLUSIONS: Delayed-enhancement MRI is a powerful predictor of myocardial viability after surgery, suggesting an important role for this technique in clinical viability assessment.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15353496     DOI: 10.1161/01.CIR.0000142045.22628.74

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  95 in total

Review 1.  Contrast agents and cardiac MR imaging of myocardial ischemia: from bench to bedside.

Authors:  Pierre Croisille; Didier Revel; Maythem Saeed
Journal:  Eur Radiol       Date:  2006-04-22       Impact factor: 5.315

Review 2.  Multimodality imaging for assessment of myocardial viability: nuclear, echocardiography, MR, and CT.

Authors:  James A Arrighi; Vasken Dilsizian
Journal:  Curr Cardiol Rep       Date:  2012-04       Impact factor: 2.931

3.  Myocardial perfusion imaging and infarct characterization using multidetector cardiac computed tomography.

Authors:  Gastón A Rodríguez-Granillo; Carlos A Ingino; Pedro Lylyk
Journal:  World J Cardiol       Date:  2010-07-21

4.  Prediction of long-term reverse left ventricular remodeling after revascularization or medical treatment in patients with ischemic cardiomyopathy: a comparative study between SPECT and MRI.

Authors:  Tomas Skala; Martin Hutyra; Jan Vaclavik; Milan Kaminek; David Horak; Josef Novotny; Jana Zapletalova; Jan Lukl; Dan Marek; Milos Taborsky
Journal:  Int J Cardiovasc Imaging       Date:  2010-08-20       Impact factor: 2.357

Review 5.  Is cardiac magnetic resonance imaging assessment of myocardial viability useful for predicting which patients with impaired ventricles might benefit from revascularization?

Authors:  Nicholas M Child; Rajiv Das
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-01-25

Review 6.  Cardiovascular MR to access myocardial viability in chronic ischaemic LV dysfunction.

Authors:  T A M Kaandorp; H J Lamb; E E van der Wall; A de Roos; J J Bax
Journal:  Heart       Date:  2005-10       Impact factor: 5.994

Review 7.  Clinical applications of cardiovascular magnetic resonance imaging.

Authors:  Constantin B Marcu; Aernout M Beek; Albert C van Rossum
Journal:  CMAJ       Date:  2006-10-10       Impact factor: 8.262

8.  Impact of scar on water-perfusable tissue index in chronic ischemic heart disease: Evaluation with PET and contrast-enhanced MRI.

Authors:  Paul Knaapen; Olga Bondarenko; Aernout M Beek; Marco J W Götte; Ronald Boellaard; Arno P van der Weerdt; Cees A Visser; Albert C van Rossum; Adriaan A Lammertsma; Frans C Visser
Journal:  Mol Imaging Biol       Date:  2006 Jul-Aug       Impact factor: 3.488

Review 9.  Post myocardial infarction of the left ventricle: the course ahead seen by cardiac MRI.

Authors:  Pier Giorgio Masci; Jan Bogaert
Journal:  Cardiovasc Diagn Ther       Date:  2012-06

Review 10.  The prognostic value of late gadolinium enhancement CMR in nonischemic cardiomyopathies.

Authors:  Theodoros D Karamitsos; Stefan Neubauer
Journal:  Curr Cardiol Rep       Date:  2013-01       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.